New trials, publications, preprints and grants on this target, month by month.
Trial
GD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid Tumors
1 Oct 2027· PHASE1 · NOT_YET_RECRUITING· CTGOV
Trial
Low-Dose Apatinib Plus Chemotherapy in ADC-Pretreated HER2-Positive and HER2-Low Advanced Breast Cancer
1 Mar 2027· PHASE2 · NOT_YET_RECRUITING· CTGOV
Trial
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors
1 Jan 2027· PHASE1 · NOT_YET_RECRUITING· CTGOV
Trial
A Study to Learn the Safety and Efficacy of HLX37 in Combination With Chemotherapy for First-line Treatment in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
30 Nov 2026· PHASE2_PHASE3 · NOT_YET_RECRUITING· CTGOV
Trial
A Phase II/III Multicenter, Randomized, Masked, Active Comparator-Controlled Study to Evaluate the Safety and Efficacy of Two Doses of OCUL101, an Anti-VEGF and Anti-Complement C5, Bi-specific Humanized Antibody-Like “trap” in Participants with Neovascular Age-Related Macular Degeneration with or without Geographic Atrophy – STAT Study
8 Nov 2026· PHASE2_PHASE3 · NOT_YET_RECRUITING· CTIS
Publication
TAVO412, an Anti-EGFR, cMET and VEGF Trispecific Antibody: Initial Results from a Phase I Dose Escalation Study in Patients with Advanced Solid Tumors.
6 Nov 2026· The oncologist· PUBMED
Publication
HB0025, a Novel Anti-PD-L1/VEGF Trap Bispecific Antibody Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer.
5 Nov 2026· JAMA oncology· PUBMED
Publication
A pathway-level analysis reveals oxidative and inflammatory vascular stress signatures associated with VEGF inhibition.
4 Nov 2026· Vascular pharmacology· PUBMED
Publication
A tetravalent bispecific protein enables targeted degradation of VCAM-1 and VEGFR for treatment of choroidal neovascularization.
4 Nov 2026· Proceedings of the National Academy of Sciences of the United States of America· PUBMED
Publication
Neu_SPP1 neutrophils are associated with anti-PD-1 resistance in non-small cell lung cancer and implicate VEGF signaling.
2 Nov 2026· Chinese medical journal· PUBMED
Trial
South Asian Patients With Diabetic Macular Oedema Treated With Faricimab Assessing the Efficacy, Durability, and Safety (SEAFAR Study)
1 Nov 2026· PHASE4 · NOT_YET_RECRUITING· CTGOV
Trial
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)
1 Nov 2026· PHASE2_PHASE3 · NOT_YET_RECRUITING· CTGOV
Trial
The Effects of High-Intensity Interval Training on Gait, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis
1 Nov 2026· NA · NOT_YET_RECRUITING· CTGOV
Publication
Preclinical Evaluation of cRGD-Functionalized Lipid-Polymer Hybrid Nanocarriers for Anti-VEGF Gene Therapy in Triple-Negative Breast Cancer.
1 Nov 2026· Drug development research· PUBMED
Publication
Leuprorelin Suppresses Angiogenesis and Malignant Progression in Endometrial Cancer via Downregulation of the ELAVL1/VEGFA Axis.
1 Nov 2026· Journal of biochemical and molecular toxicology· PUBMED
Publication
Non-Canonical Function of ORC1: Regulating Notch-VEGFR2-Mediated Angiogenesis in Melanoma Progression.
1 Nov 2026· Pigment cell & melanoma research· PUBMED
Publication
Design, Synthesis, In Vitro Biological Evaluation, and In Silico Studies of Novel Imidazo[4,5-b]Pyridine-Acrylonitrile-Based Derivatives as VEGFR-2 Inhibitors Against Breast Cancer and Hepatocellular Carcinoma.
1 Nov 2026· Drug development research· PUBMED
Publication
PD-(L)1×VEGF bispecific antibodies in solid tumors: clinical trial updates from ASCO 2026.
31 Oct 2026· Journal of hematology & oncology· PUBMED
Trial
A First-in-human Trial of SZN-8141 in Diabetic Macular Edema
30 Oct 2026· PHASE1 · NOT_YET_RECRUITING· CTGOV
Trial
Real-World Treatment Patterns and Effectiveness of Anti-EGFR- and Anti-VEGF-based Therapies in Left-sided RAS Wild-Type Metastatic Colorectal Cancer
30 Oct 2026· NA · NOT_YET_RECRUITING· CTGOV
Publication
Submacular Hemorrhage Requiring Procedural Intervention During Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration in Japan: The JTY Three-Center Real-World Incidence Study.
30 Oct 2026· Retina (Philadelphia, Pa.)· PUBMED
Publication
Growth factor VEGF-B sustains intestinal Tfh cell stemness to restrict Taurinivorans outgrowth and microbiota-driven obesity.
29 Oct 2026· Immunity· PUBMED
Publication
Time Course of Resolution of Diabetic Macular Edema by Sustained Suppression of VEGF-A with the Port Delivery Platform with Ranibizumab.
27 Oct 2026· American journal of ophthalmology· PUBMED
Publication
Impact of Anti-VEGF treatment on retinal anatomy and electrophysiological function in diabetic macular edema.
27 Oct 2026· Documenta ophthalmologica. Advances in ophthalmology· PUBMED
Publication
Floralozone alleviates doxorubicin-induced cardiac senescence and fibrosis by inhibiting the VEGFR1.
27 Oct 2026· Molecular biology reports· PUBMED
Publication
Dual VEGF and PD-(L)1 Blockade: Facts and Hopes.
26 Oct 2026· Clinical cancer research : an official journal of the American Association for Cancer Research· PUBMED
Publication
Outcomes of subthreshold diode micropulse laser and anti-VEGF vs anti-VEGF monotherapy for diabetic macular edema: a meta-analysis.
26 Oct 2026· Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie· PUBMED
Publication
Evaluation of FGFR2, VEGFA, and MMP1 gene variants for ovarian cancer susceptibility among South Indian women: a hospital-based case-control study.
25 Oct 2026· Molecular biology reports· PUBMED
Publication
VEGFR2-dependent VEGFR3 expression leads to CXCL1/2 and CXCR2 induction in the development of retinal neovascularization.
25 Oct 2026· Angiogenesis· PUBMED
Publication
Ziyin Huatan Recipe Inhibits Lymph Node Metastasis in Gastric Cancer via Downregulating PLAG1-Mediated VEGF-C/VEGFR-3 Signaling.
24 Oct 2026· Chinese journal of integrative medicine· PUBMED